Fri Apr 25 07:52:32 SGT 2014  
SINGAPORE
GENITAL™
    Genital warts treatment, Singapore (SG)
HIV STD TESTING TREATMENT™
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

Genital warts treatment, Singapore (SG) | HIV STD TESTING TREATMENT™

Summary

Genital warts treatment, Singapore (SG) | HIV STD TESTING TREATMENT™ @singaporegenital_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital warts treatment, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute Alere™ Determine™ Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

High-throughput and automatic typing via human papillomavirus identification map for cervical cancer screening and prognosis
Tue, 22 Apr 2014 15:42:18 +0100 | RSC - Analyst latest articles
Analyst, 2014, Accepted ManuscriptDOI: 10.1039/C4AN00329B, PaperLinglu Yi, Xueqin Xu, Xuexia Lin, Haifang Li, Yuan Ma, Jin-Ming LinA novel human papillomavirus (HPV) typing assay for cervical cancer screening and prognosis was developed on combination of restriction fragment length polymorphism (RFLP) and microchip electrophoresis (MCE) to achieve higher...The content of this RSS Feed (c) The Royal Society of Chemistry (Source: RSC - Analyst latest articles)

Global Health: Cancer Vaccine Proves Effective in H.I.V. Patients
Mon, 21 Apr 2014 21:45:58 +0100 | NYT
Vaccines against cervical cancer work well even in sexually active women with H.I.V., a new study has found. (Source: NYT)

Opportunities for Increasing Human Papillomavirus Vaccine Provision in School Health Centers
Mon, 21 Apr 2014 00:00:00 +0100 | Journal of School Health
CONCLUSIONSAlthough school health centers reported facing several key barriers to providing HPV vaccine, many were interested in partnering with outside organizations on low‐cost interventions to increase HPV vaccine uptake among adolescents. (Source: Journal of School Health)

Cervical Screening and Cervical Cancer Death Among Older Women: A Population-Based, Case-Control Study
Mon, 21 Apr 2014 00:00:00 +0100 | American Journal of Epidemiology
Recent research suggests that cervical screening of older women is associated with a considerable decrease in cervical cancer incidence. We sought to quantify the efficacy of cervical cytology screening to reduce death from this disease. Among enrollees of 2 US health plans, we compared Papanicolaou smear screening histories of women aged 55–79 years who died of cervical cancer during 1980–2010 (cases) to those of women at risk of cervical cancer (controls). Controls were matched 2:1 to cases on health plan, age, and enrollment duration. Cytology screening during the detectable preclinical phase, estimated as the 5–7 years before diagnosis during which cervical neoplasia is asymptomatic but cytologically detectable, was ascertained from medical records. A total of 39 case...

Relationship between HPV and the biomarkers annexin A1 and p53 in oropharyngeal cancer
Mon, 21 Apr 2014 00:00:00 +0100 | Infectious Agents and Cancer
Conclusions:

HPV just as serious for men as women
Fri, 18 Apr 2014 10:00:00 +0100 | bizjournals.com Health Care:Pharmaceuticals headlines
When HPV (human papillomavirus) is in the news, it is usually because of some controversy surrounding the vaccine – such as if boys as well as girls should be vaccinated, what age the vaccine should be given and if being vaccinated encourages sexual activity. But because these discussions tend to focus on how HPV can cause cervical cancer in women, few may realize the potential health problems HPV can cause in men.

Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: Implications for tonsil cancer precursor lesions
Fri, 18 Apr 2014 00:00:00 +0100 | International Journal of Cancer
The incidence of human papillomavirus (HPV)‐associated tonsil cancer is increasing but the prevalence of HPV, and of premalignant precursors, in tonsil tissue is unknown. We aimed to assess prevalence of HPV infection in nonmalignant tonsillar crypt epithelia and to histopathologically characterise positive samples. Formalin‐fixed paraffin‐embedded (FFPE) tonsil tissue specimens were obtained from an age‐ and sex‐stratified random sample of patients aged 0–69 years whose paired tonsils were archived following elective tonsillectomy at hospitals throughout England and Southern Scotland from 2004 to 2008. Homogenised fresh‐frozen tonsil tissue was also obtained from archive for two random subsets of males aged 25–34 and over 44. HPV status was assessed in all samples for 20 m...

Virus transcript levels and cell growth rates after naturally‐occurring HPV16 integration events in basal cervical keratinocytes
Thu, 17 Apr 2014 23:06:16 +0100 | The Journal of Pathology
Abstract

The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: An update of recent developments
Thu, 17 Apr 2014 00:00:00 +0100 | International Journal of Cancer
Abstract

Efficacy, immunogenicity and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomised controlled trial
Thu, 17 Apr 2014 00:00:00 +0100 | International Journal of Cancer
Abstract